NA

Natures Sunshine Products IncNASDAQ NATR Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0.254

Micro

Exchange

XNAS - Nasdaq

NATR Stock Analysis

NA

Neutral

Based on Eyestock quantitative analysis, NATR`s fundamental data and valuation indicate an investment grade of Neutral at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

90/100

Moderate score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

2.8 %

Undervalued

Market cap $B

0.254

Dividend yield

5.59 %

Shares outstanding

19.056 B

Nature's Sunshine Products, Inc. engages in the manufacture and sale of nutritional and personal care products. The company is headquartered in Lehi, Utah and currently employs 800 full-time employees. The company went IPO on 2009-06-25. The firm has four segments: Asia, Europe, North America, and Latin America and Other. Its segments operate under the Nature's Sunshine Products and Synergy WorldWide brands. Its products are grouped into six principal categories, such as general health, immune, cardiovascular, digestive, personal care and weight management. Its general health category is a combination of assorted health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision. Its immune category offers products that support and strengthen the human immune system. Its cardiovascular category is designed to offer products that combine a variety of superior heart health ingredients to give the cardiovascular system optimum support.

View Section: Eyestock Rating